Thus, upregulating the TSP-1 expression, especially in microglia, by blocking the EV-mediated convey of WT1 from GBM to inhibit angiogenesis might prove a good anti-GBM therapeutic strategy [94]. This evidence concerns the gene THBS1 and glioblastoma.